<SEC-DOCUMENT>0001104659-15-027652.txt : 20150415
<SEC-HEADER>0001104659-15-027652.hdr.sgml : 20150415
<ACCEPTANCE-DATETIME>20150415151524
ACCESSION NUMBER:		0001104659-15-027652
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20150415
FILED AS OF DATE:		20150415
DATE AS OF CHANGE:		20150415

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			uniQure N.V.
		CENTRAL INDEX KEY:			0001590560
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36294
		FILM NUMBER:		15771524

	BUSINESS ADDRESS:	
		STREET 1:		MEIBERGDREFF 61
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1005 BA
		BUSINESS PHONE:		31-20-5667394

	MAIL ADDRESS:	
		STREET 1:		MEIBERGDREFF 61
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1005 BA

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	uniQure B.V.
		DATE OF NAME CHANGE:	20131030
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a15-9223_16k.htm
<DESCRIPTION>6-K
<TEXT>


<html>
<head>

  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<div style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 3.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, D.C. 20549</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM&nbsp;6-K</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Report of Foreign Private Issuer</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Pursuant to Rule&nbsp;13a-16 or 15d-16 of</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">the Securities Exchange Act of 1934</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">April&nbsp;15, 2015</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">uniQure N.V.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">J&#246;rn Aldag, Chief Executive Officer<br> Meibergdreef 61<br> Amsterdam 1105 BA, the Netherlands; Tel: +31 20 566 7394</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address,&nbsp;Including ZIP Code, and Telephone Number,</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Including Area Code, of Registrant&#146;s Principal Executive Offices)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form&nbsp;20-F or Form&nbsp;40-F.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form&nbsp;20-F&nbsp;</font><font size="2" face="Wingdings" style="font-size:10.0pt;">x</font><font size="2" style="font-size:10.0pt;">&nbsp;&nbsp;Form&nbsp;40-F&nbsp;</font><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indicate by check mark if the registrant is submitting the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101(b)(1):&nbsp;</font><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indicate by check mark if the registrant is submitting the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101(b)(7):&nbsp;</font><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="border-bottom:solid windowtext 3.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\108645\15-9223-1\task7338723\9223-1-ba.htm',USER='108645',CD='Apr 15 16:14 2015' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Furnished as Exhibit&nbsp;99.1 to this Report on Form&nbsp;6-K is a press release of uniQure N.V. dated April&nbsp;15, 2015, announcing the closing of the follow-on public offering of the Company&#146;s ordinary shares.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2<a name="PB_2_160657_7056"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\108645\15-9223-1\task7338723\9223-1-ba.htm',USER='108645',CD='Apr 15 16:14 2015' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURES</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.42%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">UNIQURE N.V.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.26%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:   April&nbsp;15, 2015</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/S/   J&#214;RN ALDAG</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">J&#246;rn   Aldag</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief   Executive Officer</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3<a name="PB_3_160755_5335"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\108645\15-9223-1\task7338723\9223-1-ba.htm',USER='108645',CD='Apr 15 16:14 2015' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">INDEX TO EXHIBITS</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="8%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:8.64%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Number</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="89%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:89.22%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Description</font></b></p>    </td>   </tr>
<tr>
<td width="8%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:8.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="89%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:89.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="8%" valign="top" style="padding:0in 0in 0in 0in;width:8.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="89%" valign="top" style="padding:0in 0in 0in 0in;width:89.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press   release of uniQure N.V. dated April&nbsp;15, 2015, announcing the closing of   the follow-on public offering of the Company&#146;s ordinary shares.</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4<a name="PB_4_160815_5796"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\108645\15-9223-1\task7338723\9223-1-ba.htm',USER='108645',CD='Apr 15 16:14 2015' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a15-9223_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>


<html>
<head>


  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;99.1</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman"><img width="223" height="61" src="g92231mmi001.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">uniQure Announces Closing of Follow-on Public Offering</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Amsterdam, the Netherlands, April&nbsp;15, 2015 </font></b><font size="2" style="font-size:10.0pt;">&#151; uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced the closing of its previously announced follow-on public offering of 3,000,000 ordinary shares at an offering price of $29.50 per ordinary share. In addition, uniQure has granted the underwriters a 30-day option to purchase up to an additional 450,000 ordinary shares from uniQure at the offering price, less underwriting discounts.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Leerink Partners LLC, Cowen and Company, LLC, and Piper Jaffray&nbsp;&amp; Co. acted as the joint book-running managers for the offering. Oppenheimer &amp; Co. Inc. and H.C. Wainwright&nbsp;&amp; Co., LLC, acted as co-managers.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A shelf registration statement relating to these securities was declared effective by the Securities and Exchange Commission on March 13, 2015. The offering was made only by means of a prospectus supplement, copies of which may be obtained from Leerink Partners LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, email:Syndicate@Leerink.com, phone: (800) 808-7525 ext. 6142; Cowen and Company, LLC, Attention: Prospectus Department, c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, NY, 11717, phone: 631-274-2806, fax: 631-254-7140; or Piper Jaffray&nbsp;&amp; Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, phone: 1-800-747-3924, email: prospectus@pjc.com.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About uniQure</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">uniQure is delivering on the promise of gene therapy through single treatments with potentially curative results. We have developed a modular platform to rapidly bring new disease-modifying therapies to patients with severe disorders. We are engaged in multiple partnerships and have obtained regulatory approval of our lead product, Glybera, in the European Union for a subset of patients with LPLD.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">uniQure:</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Aicha Diba</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investor Relations</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Direct&nbsp;: +31 20 240 6100</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Main: +31 20 240 6000</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">a.diba@uniQure.com</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Media inquiries:</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gretchen Schweitzer</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">MacDougall Biomedical Communications</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Direct: +49 172 861 8540</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Main: +49 89 2424 3494 or +1 781 235 3060</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">gschweitzer@macbiocom.com</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\jms\108710\15-9223-1\task7338788\9223-1-mm.htm',USER='108710',CD='Apr 15 17:05 2015' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g92231mmi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g92231mmi001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"``]`-\#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:BBB@`HH
MHH`****`"BBB@`JCJ&L6.F%1=SA&;D*`22/7`J]7!>+K.Y367N61VAE5=C@9
M`P,8KBQM>="ESP5V=N!P\,15Y)NR.VM+RWOX!/;2K)&>,CL?2IZYGP5:7$%I
M<33(R1S,-BL,9QU/^?2MK5-0BTNPDNI1G;PJ_P!YCT%:4*[E056HK::D5Z"C
M7=*F[ZZ%F26.%"\KJBCJS'`JG_;FE;MO]H6^?]\5Y[J&I7>J7!EN9"Q)^5!]
MU?8"G'1M3$/FFPGV8SG9V^E>5+-IRD_90ND>K'*81BO:SLW_`%U/3(Y$E0/&
MZNIZ,IR#3Z\OTW5+O2IQ+;2$#/S1G[K?45Z-IU_%J5C'=0\*XY!ZJ>XKNP>.
MAB;JUFNAP8S`3PUG>\7U+5%%%>@>>%%%%`!1110`4444`%%%%`!1110!B>)M
M7N=(@@>V$9,CE3O!/;ZU!X:UV\U>YGCN1$!&@8;%([_6H/'7_'I:?]=#_*JG
M@;_C^NO^N0_G7BSKU%F"I\WN]OD>W"A3>7.IR^]W^9UM],]O87$Z8W1QLRYZ
M9`KD+'Q=J=Q?6\+K;[9)%5L(<X)^M=7JO_((O/\`K@_\C7G&E?\`(5L_^NR?
MS%&8UZE.M!0E9/\`S#+:%.I1FYQNU_D>H.2J,1U`)KAE\::IN&Y;?&>?D/3\
MZ[B7_5/_`+IKR?OQ1FM>I2<.1VO?]`RFA2JJ?/&]K?J=+?>-;MY2+*)(HP>&
M<;F/]!3M/\:W"S*M_$CQ$\O&,%??'>M6R\(Z:EFJW,1FF9<L^\C!]L5R&LZ>
M-+U26U5BR+@H3UP:Y:\L=ATJLY;]/^`==".`Q#=&$=NO_!/3(W66-9$8,K#*
MD="*YOQ'X@O=*U!+>W6(HT88[U).<GW]JN>$Y6E\/PACG8S*/H#7/^-O^0S%
M_P!<!_,UWXS$3^J*K!V;L>?@\/#ZXZ4U=*YT?AO5+C5K!Y[D('60J-@P,8'^
M-97CJ8B.S@!X+,Y_#`'\S5GP3_R")?\`KN?Y"J'CK_CYL_\`<;^8K*O4E++N
M9O5V_,UH4XQS+E2T5_R*O@VTCN-6>610WD1[E!_O$X!_G7>5QG@4?Z5>'_87
M^9KLZWRN*6&376YAFLF\2T^EC@/%]G':ZSOC4*)T#D#UR0:UO`TS-:W4)/".
M&`^H_P#K53\<?\A"V_ZY'^=3>!/O7W_`/_9J\^DN3,VEY_D>A5;GEB;[+\[&
MCXGUFZT@6QMA&?-+;MZD],>_O3?#.N7>KRW"W(B`C"E=BD=<^]4O'?W;'ZO_
M`.RU'X%_U]Y_NI_,UT.O4_M'V?-[O;Y',J%+^SO:<OO=_F=-JES)9Z9<W,6-
M\499=PR,UR^G>+-2N]2MK>18-DL@5L(<X/XUT>O_`/(!O?\`KBU<#HG_`"'+
M+_KNO\Z>/KU*>(A&,K)_YCR^A2J8><I1NU?\CTFZD:&TFE7&Y(V89]0*XJ'Q
MIJ/FQ^<L'E[AOVH<X[XYKLK_`/Y!]S_UR;^1KRV)&E=(U^\Y"CZFEFE>K2G!
M4W8,JH4JL)NHKG17?C6^DD/V2*.&//&X;F/U[5?T#Q->ZA>BTN+99,C/F1C&
MWW(]*N0^$-*2U$4D;228YEWD'/MVHEM(/#/AZY>UYEV\R-]YF/`_+-.%/&0G
M[2K/W5J_\K"G5P4X>RI0]YZ+_.Y!K7BV.QF:VLXUFF0X=V/RJ?3W-8H\9:L'
MR3`1_=\OC^=9VD6/]IZI#:LY"N27;O@<FNY?PWHSV_D_9$7C`=3\P]\USTY8
MS&7J0ERI'14C@L':G.',V5M$\40ZG*+:X007!^[@_*_T]_:M^O++N"33M1EA
M5_G@D^5Q[=#7I=A<_;+""Y_YZQAC]<<UVY?BYU>:G4^)'#F.$A1Y:E+X9'/>
M.O\`CTM/^NA_E53P-_Q_77_7(?SK3\9VCSZ2LR`G[.^Y@/[I&"?Y5R.E:I-I
M-Z+F$!LC:Z'HPKAQ4U1S!5)[:?E8[\+!ULO=.&^OYW/1-6.-(O,_\\'_`)&O
M.-*_Y"MG_P!=D_F*V-6\6RZC9M:PV_D+(,.Q;<2/05CZ7_R%K/\`Z[I_,5EC
ML33KUX>S=TO\S7`X:I0H3]HK-_Y'I\O^J?\`W37DX^\/K7K$O^J?_=->3C[P
M^M=&<[T_G^ASY+M4^7ZGK*?<7Z5P/B__`)&"3_KFG\J[Y/N+]*X'Q?\`\C!)
M_P!<T_E75FW^[+U7ZG+E'^\OT?Z'1^#_`/D`)_UT?^=87C;_`)#,7_7`?S-;
MO@__`)`"?]='_G6%XV_Y#,7_`%P'\S6&*_Y%T/D=&&_Y&4_F:_@G_D$2_P#7
M<_R%4_'2'?928XPXS^57/!/_`"")?^NY_D*N^)-+;5-+*1#,T1WQCU]1^(K5
M4G5RY1CO;]3'VL:68N4MK_FCG_`\@74;F,GEH@0/7!_^O70:YKT.C1JNWS9W
MY6/../4FN`MKFXT^[6:%C%-$>XZ>H(K3U3Q%_:]F(KBQC$J_=E5CE?P_I7!A
M\<J6&=-.TEL=^(P#JXI5&KQ>_P#787Q/J=OJEU;36[940_,#U4Y/!K4\"H?+
MO9.Q9%_G_C7(5Z!X2BMX]$0PR"1G8M+C^%O3\!BC`2E7QGM);[_H&81C0P?L
MH[;?C<SO'?W;'ZO_`.RU'X%_U]Y_NI_,U=\:VCS:=#<(,B!SNQV![_GBN6TC
M5IM'NS/$H=6&UT/&X5IB)JAF/M)[?\"Q&'@Z^7>SAO\`\&YWNO\`_(!O?^N+
M5P.B?\ARR_Z[K_.M+6/%<NIVAM8K?R(WQO);<3[5FZ)_R'++_KNO\ZSQF(IU
M\3!TW=*WYFF#P]2AAIJHK-W_`"/1K_\`Y!]S_P!<F_D:\RL?^/ZV_P"NJ?S%
M>FW_`/R#[G_KDW\C7F5C_P`?UM_UU3^8K?-OXM,Y\H_A5/Z[GJM8GBX$^'IL
M=F0G_OH5MU5U*S%_IT]J3CS4(!]#V_6O:Q$'.E**ZIGB8>:IUHS>R:/-;*RG
MU"Z6VM@#(P)`+8Z5I_\`"(ZS_P`\H_\`OZ*S8I+G2]0#@&.XMWY!'0^GTKJ(
M_',/E#S+&3S,<A6&*^6PL,+)-5VTU_78^KQ53%1:=!)K^O,R?^$1UG_GC'_W
M]%=IH]M+9Z3;6\P`DC3#`'/-<O;^,[HZF'FB'V5\+Y2#++[@]S7:*=RAAG!&
M>17LY?3PUY2HM]M3Q<QJ8GEC"NEWT!E#*58`@C!![USUWX+L)Y2\$LEOGJJX
M*_AFNBHKT*M"G65JBN>=2KU:+O3E8P;3PAIULK[VDFD92H9\?+D8R!ZTRW\&
MV5M<Q3K<W!:)PP!*X.#]*Z&BLOJ6'T]Q:&OUW$._OO41AN4J>XQ7-CP18@Y^
MU7'YK_A72T5K5P]*M;VBO8SI8BK1O[-VN(!@`>E8VI^&+75+UKJ6>9&90,)C
M''X5M4552E"K'EFKHFE6G2ES0=F4]+TZ/2K,6L3NZABV7QGGZ53U;PY;:O=+
M<332HRILPF,8R3W'O6Q14RH4Y05-K3L.->I&HZB>KZE'2=*ATBV:"&1W5GWD
MOC.<>WTJ]116D(1A%1BM$1.<IR<I.[9F:EX?T_5&\R:,I+_STC."?KZUD_\`
M"#6V[_C]FQZ;174T5SU,'0J2YI15SHIXW$4X\L9.Q@2>#]--B\$0=9CRLS')
M!_PJUH.B)HUL06WSR8,CCI]!6K13CA:,)J<8V:)GBZ\X.$I73&NBR(4=0RL,
M$$9!%<]=>"K":0O!-+`#_`,,!],UT=%75H4JRM4C<BCB*M%WIRL8-KX0TZWB
MD#&261U*AVQ\N>X'3--M/!]G9W<5REQ.S1.&`)7!Q^%=!16:P>'5K06AJ\;B
M'>\WJ,FB$T$D3$@.I4D>XKGX?!=C#-'*MS<$QL&`)7L?I71T5I4P]*JTYJ]C
M.EB*M)-0=KA1116Q@9NIZ%8:J=]Q&1*!@2(<-_\`7K(/@:VSQ>S8]-HKJ:*Y
M:F#H5'S3CJ=5/&8BE'EA+0R=-\-Z?ICB6-&EF'220Y(^G85K445M3IPIQY8*
+R,:E6=67--W9_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
